This is a pilot study with pharmacology of foscarnet for the treatment of upper and lower gastrointestinal cytomegalovirus infection in AIDS patients. The study will investigate the safety and tolerance of foscarnet administered in a 2-hour intravenous infusion at 90 mg/kg of body weight every 12 hours for 14 consecutive days.
|Effective start/end date||1/10/92 → 30/09/94|
- National Center for Research Resources
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.